Company profile
Employees
Incorporated
Location
Fiscal year end
Former names
Cambrian BioPharma Inc.
SEC CIK
IRS number
842985609
Latest filings (excl ownership)
D
$40.00 mm in other securities, sold $7.69 mm, 20 investors
22 Dec 23
D
$100.78M in equity / options, sold $92.21M, 56 investors
2 Dec 21
D
$28.43M in equity / debt / options, sold $28.43M, 30 investors
6 May 21
D
$4.75M in equity / options / securities to be acquired, sold $4.75M, 5 investors
27 Jan 20
Latest ownership filings
SC 13G/A
Sensei Biotherapeutics, Inc.
4 Aug 23
4
Sensei Biotherapeutics, Inc.
2 Aug 23
4
Sensei Biotherapeutics, Inc.
12 Jul 23
4/A
Sensei Biotherapeutics, Inc.
7 Mar 23
SC 13G/A
Sensei Biotherapeutics, Inc.
14 Feb 23
SC 13G/A
Peyer James
13 Feb 23
4
Sensei Biotherapeutics, Inc.
14 Jun 22
SC 13G/A
Sensei Biotherapeutics, Inc.
10 Jun 22
4/A
Sensei Biotherapeutics, Inc.
10 Jun 22
4/A
Sensei Biotherapeutics, Inc.
21 Apr 22
Institutional ownership, Q4 2023
13F holders | Current |
---|---|
Total holders | 15 |
Opened positions | 1 |
Closed positions | 12 |
Increased positions | 1 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 1.62 bn |
Total shares | 15.82 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
James Peyer | 5.24 mm | $0.00 |
H&S Investments I | 4.44 mm | $0.00 |
Cambrian BioPharma | 3.65 mm | $4.60 mm |
Newtyn Management | 1.57 mm | $1.09 bn |
Vanguard | 573.65 k | $396.97 mm |
Renaissance Technologies | 143.51 k | $99.00 k |
Bridgeway Capital Management | 112.90 k | $78.13 mm |
NTRS Northern Trust | 26.05 k | $18.03 mm |
STT State Street | 25.77 k | $17.84 mm |
Leo Wealth | 14.85 k | $10.27 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Jul 23 | Cambrian BioPharma | Common Stock | Sale back to company | Dispose D | No | No | 1.26 | 1,587,302 | 2.00 mm | 3,653,120 |
10 Jul 23 | Cambrian BioPharma | Common Stock | Grant | Acquire A | No | No | 0 | 4,466 | 0.00 | 5,240,422 |
10 Jul 23 | Cambrian BioPharma | Stock Option Common Stock | Grant | Acquire A | No | No | 1.22 | 14,550 | 17.75 k | 14,550 |